Welcome to The Conference
We are delighted to invite you to attend our 8th international Oxford conference on antisense and therapeutic nucleic acids. We are currently planning to hold this conference as a ‘virtual-in-person’ hybrid event. However, due to the COVID-19-related uncertainties, the decision to hold the ‘in-person’ element of this event will be taken in early 2022.
The conference is aimed at bringing together chemists and biologists from academia and industry to discuss the latest advances and breakthroughs in the development of synthetic oligonucleotides as therapeutics, featuring:
>High-impact talks and discussions
>An international faculty of senior and emerging researchers from academia and industry
Get involved in shaping the conference agenda: We invite oral and poster abstracts on therapeutic applications of nucleic acids, including:
>Antisense & catalytic oligonucloetides, aptamers, siRNAs, miRNAs, antagomirs/blockmirs
>Gene therapy and genome editing
>Chemical modification of nucleic acids
>Nucleic acid delivery strategies
We particularly encourage final year doctoral students and early/mid-career postdoctoral researchers/junior group leaders to submit abstracts, as we believe this event will provide their research an excellent exposure, critical analysis by attending senior researchers and new career opportunities.
Our accompanying aptamers meeting, Aptamers 2022, will be held on 04-05 April 2022.
Oral Abstracts: 31 Dec 2021 | Early Registration: 31 Dec 2021 | Poster Abstracts: 18 Mar 2022 | Standard Registration: 28 Mar 2022 | Digital Posters: 28 Mar 2022